Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Medtronic recalls MiniMed pump models on cybersecurity risk

June 27, 2019 By Brad Perriello

Medtronic logo updatedMedtronic (NYSE:MDT) today recalled two models of its MiniMed insulin pumps after researchers discovered cybersecurity risks that could allow a hacker to take control of the devices.

The recall affects 11 models in Fridley, Minn.-based Medtronic’s line of MiniMed 508, MiniMed Paradigm and MiniMed Paradigm Veo pumps, according to the FDA. Medtronic said the pumps are designed to wirelessly communicate with other devices such as glucose meters, glucose sensor transmitters and its own CareLink USB devices.

“Security researchers have identified potential cybersecurity vulnerabilities related to these insulin pumps. An unauthorized person with special technical skills and equipment could potentially connect wirelessly to a nearby insulin pump to change settings and control insulin delivery. This could lead to hypoglycemia (if additional insulin is delivered) or hyperglycemia and diabetic ketoacidosis (if not enough insulin is delivered),” Medtronic said in a field alert dated today.

There have been no confirmed reports of unauthorized hackers changing settings or controlling insulin delivery, the company said. Patients using the pumps listed below are advised to switch to devices “that are better equipped to protect against these potential risks,” the federal safety watchdog said.

Here is a list of the affected devices:

Pump Model Software Version
MiniMed™ 508 All versions
MiniMed™ Paradigm™ 511 All versions
MiniMed™ Paradigm™ 512/712 All versions
MiniMed™ Paradigm™ 515/715 All versions
MiniMed™ Paradigm™ 522/722 All versions
MiniMed™ Paradigm™ 522K/722K All versions
MiniMed™ Paradigm™ 523/723 Version 2.4A or lower
MiniMed™ Paradigm™ 523K/723K Version 2.4A or lower
MiniMed™ Paradigm™ 712E* All versions
MiniMed™ Paradigm™ Veo 554CM/754CM* Version 2.7A or lower
MiniMed™ Paradigm™ Veo 554/754* Version 2.6A or lower

Filed Under: Diabetes, Featured, Food & Drug Administration (FDA), Recalls Tagged With: Medtronic

IN CASE YOU MISSED IT

  • 3M to sell drug-delivery biz to Altaris Capital Partners for $650m
  • Medicina recalls IV Luer Slip syringes
  • Eitan Group signs service agreement with Integrated Medical Systems
  • Beta Bionics’ bionic pancreas wins breakthrough status from FDA
  • FDA details framework for abbreviated 510(k) medical device review pathway

Comments

  1. Phillip Reitz says

    June 28, 2019 at 1:55 pm

    I have and been using Medtronic Insulin Pump,ref mmt 723RNAS, SN PAR814897U. Is this unit involved in the cybo security threat???
    Please advise what actions if any I must take????
    Thanks, Phil Reitz.

  2. Tracy King says

    July 25, 2019 at 8:22 pm

    Paradigm pump recalls for the 723 is based on your software version. Go to your status screen (press esc from home screen) and scroll down to the bottom. The last line is software version. If you have 2.4A or lower you are in the recall. If your software version in higher it is still safe (for now). Go to the MiniMed website for the patient letter. And you should never give your serial number out like you just did above. Hackers must have your serial number to communicate with your pump. Be safe!

Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by DrugDeliveryNow

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
Medical Tubing + Extrusion

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery News
Advertise with us
About
Contact us
Privacy
Add us on FacebookDrug Delivery Business News
Follow us on Twitter@DrugDeliveryNow
Connect with us on LinkedInLinkedIn

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS